Post-COVID-19 Autoimmune Rhombencephalitis

Case Study Highlights Neurological Risks

A recent case study published in Cureus describes a rare instance of autoimmune rhombencephalitis, an inflammatory disease affecting the brainstem and cerebellum that can cause weakness, facial paralysis, and speech difficulties, adding to growing concerns about the virus’s neurological complications. The report details a 31-year-old male who developed severe brainstem and cerebellar inflammation two weeks after recovering from a mild COVID-19 infection. His symptoms included unilateral weakness, facial droop, slurred speech, and altered mental status.

Despite an extensive infectious and autoimmune workup, no clear alternative cause was found, leading to a diagnosis of post-infectious autoimmune rhombencephalitis. Treatment with high-dose corticosteroids led to significant recovery, reinforcing the role of immunotherapy in managing COVID-19-related neurological sequelae.

This case underscores the importance of recognizing autoimmune-mediated neurological disorders as potential post-COVID-19 complications. It also highlights the need for early intervention with immunosuppressive therapy to improve outcomes. As autoimmune diseases continue to be linked to viral infections, further research is needed to understand the long-term neurological impact of COVID-19.

Citation

Mohamed A S, Jahani N, Li M, et al. (February 23, 2025) Autoimmune Rhombencephalitis as a Presentation of Post-COVID-19 Syndrome: A Case Report. Cureus 17(2): e79517. doi:10.7759/cureus.79517